Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Fleischer

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 12, 2017
The allergenicity of genetically modified foods from genetically engineered crops: A narrative and systematic reviewS Eliza Dunn, John L Vicini, Kevin C Glenn, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2004
Peanut allergy: recurrence and its managementDavid M Fleischer, Mary Kay Conover-Walker, Lynn Christie, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 1, 2020
Post hoc analysis of epicutaneous immunotherapy for peanut allergy phase 3 results: Relevance for exposure through restaurant mealsBenjamin C Remington, Dianne E Campbell, Todd D Green, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 18, 2019
Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendationsElissa M Abrams, Lianne Soller, Alexander G Singer, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2018
Additional oral food challenge considerationsJ Andrew Bird, David M Fleischer, Marion Groetch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2020
Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 yearsMatthew Greenhawt, Edwin H Kim, Dianne E Campbell, et al.
Expert Review of Clinical Immunology|February 7, 2024
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergyChristophe Dupont, A Wesley Burks, David M Fleischer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2024
Upper respiratory tract infections have minimal impact on neffy's pharmacokinetics or pharmacodynamicsJohn Oppenheimer, Thomas B Casale, Carlos A Camargo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 1, 2020
Different Measures of Diet Diversity During Infancy and the Association with Childhood Food Allergy in a UK Birth Cohort StudyCarina Venter, Kate Maslin, John W Holloway, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 11, 2018
Caregiver and expecting caregiver support for early peanut introduction guidelinesMatthew Greenhawt, Edmond S Chan, David M Fleischer, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 12, 2017
The allergenicity of genetically modified foods from genetically engineered crops: A narrative and systematic reviewS Eliza Dunn, John L Vicini, Kevin C Glenn, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2004
Peanut allergy: recurrence and its managementDavid M Fleischer, Mary Kay Conover-Walker, Lynn Christie, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 1, 2020
Post hoc analysis of epicutaneous immunotherapy for peanut allergy phase 3 results: Relevance for exposure through restaurant mealsBenjamin C Remington, Dianne E Campbell, Todd D Green, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 18, 2019
Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendationsElissa M Abrams, Lianne Soller, Alexander G Singer, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2018
Additional oral food challenge considerationsJ Andrew Bird, David M Fleischer, Marion Groetch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2020
Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 yearsMatthew Greenhawt, Edwin H Kim, Dianne E Campbell, et al.
Expert Review of Clinical Immunology|February 7, 2024
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergyChristophe Dupont, A Wesley Burks, David M Fleischer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2024
Upper respiratory tract infections have minimal impact on neffy's pharmacokinetics or pharmacodynamicsJohn Oppenheimer, Thomas B Casale, Carlos A Camargo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 1, 2020
Different Measures of Diet Diversity During Infancy and the Association with Childhood Food Allergy in a UK Birth Cohort StudyCarina Venter, Kate Maslin, John W Holloway, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 11, 2018
Caregiver and expecting caregiver support for early peanut introduction guidelinesMatthew Greenhawt, Edmond S Chan, David M Fleischer, et al.
Pageof 13